requires one-time free registration

AIDS

www.medscape.com/viewpublication/744

Volume 18, Number 15

• Immunologic and clinical responses to HAART over 50 years of age. Results from the French hospital database on HIV
• Cost-effectiveness of HIV PEP following sexual or injection drug exposure in 96 metropolitan areas in the United States

Volume 18, Number 14

• Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions
• Response to HAART varies with age: the UK and Ireland Collaborative HIV Paediatric Study

JAIDS: Journal of Acquired Immune Deficiency Syndromes

www.medscape.com/viewpublication/878_index

Volume 37, Number 2

• Impact of HAART on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women’s Interagency HIV Study
• Progressive Multifocal Leukencephalopathy (PML) in Patients on HAART: survival and risk factors of death